325 related articles for article (PubMed ID: 23099416)
1. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.
Hansen N; Grünewald B; Weishaupt A; Colaço MN; Toyka KV; Sommer C; Geis C
Exp Neurol; 2013 Jan; 239():202-9. PubMed ID: 23099416
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin.
Sommer C; Weishaupt A; Brinkhoff J; Biko L; Wessig C; Gold R; Toyka KV
Lancet; 2005 Apr 16-22; 365(9468):1406-11. PubMed ID: 15836889
[TBL] [Abstract][Full Text] [Related]
3. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition.
Geis C; Weishaupt A; Hallermann S; Grünewald B; Wessig C; Wultsch T; Reif A; Byts N; Beck M; Jablonka S; Boettger MK; Üçeyler N; Fouquet W; Gerlach M; Meinck HM; Sirén AL; Sigrist SJ; Toyka KV; Heckmann M; Sommer C
Brain; 2010 Nov; 133(11):3166-80. PubMed ID: 20884644
[TBL] [Abstract][Full Text] [Related]
4. Human stiff-person syndrome IgG induces anxious behavior in rats.
Geis C; Weishaupt A; Grünewald B; Wultsch T; Reif A; Gerlach M; Dirkx R; Solimena M; Perani D; Heckmann M; Toyka KV; Folli F; Sommer C
PLoS One; 2011 Feb; 6(2):e16775. PubMed ID: 21346811
[TBL] [Abstract][Full Text] [Related]
5. [Stiff-person syndrome and related autoantibodies].
Tomioka R; Tanaka K
Brain Nerve; 2013 Apr; 65(4):395-400. PubMed ID: 23568987
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.
Manto MU; Laute MA; Aguera M; Rogemond V; Pandolfo M; Honnorat J
Ann Neurol; 2007 Jun; 61(6):544-51. PubMed ID: 17600364
[TBL] [Abstract][Full Text] [Related]
7. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.
Skorstad G; Hestvik AL; Torjesen P; Alvik K; Vartdal F; Vandvik B; Holmøy T
Eur J Neurol; 2008 Sep; 15(9):973-80. PubMed ID: 18637036
[TBL] [Abstract][Full Text] [Related]
8. Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
Chang T; Alexopoulos H; McMenamin M; Carvajal-González A; Alexander SK; Deacon R; Erdelyi F; Szabó G; Lang B; Blaes F; Brown P; Vincent A
JAMA Neurol; 2013 Sep; 70(9):1140-9. PubMed ID: 23877118
[TBL] [Abstract][Full Text] [Related]
9. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.
Rizzi M; Knoth R; Hampe CS; Lorenz P; Gougeon ML; Lemercier B; Venhoff N; Ferrera F; Salzer U; Thiesen HJ; Peter HH; Walker UA; Eibel H
PLoS One; 2010 May; 5(5):e10838. PubMed ID: 20520773
[TBL] [Abstract][Full Text] [Related]
10. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
Rakocevic G; Raju R; Dalakas MC
Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
[TBL] [Abstract][Full Text] [Related]
11. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
12. Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome.
Espay AJ; Chen R
Muscle Nerve; 2006 Dec; 34(6):677-90. PubMed ID: 16969837
[TBL] [Abstract][Full Text] [Related]
13. [Stiff-person syndrome and other myelopathies constitute paraneoplastic neurological syndromes].
Ishii A
Brain Nerve; 2010 Apr; 62(4):377-85. PubMed ID: 20420178
[TBL] [Abstract][Full Text] [Related]
14. Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer.
Geis C; Grünewald B; Weishaupt A; Wultsch T; Toyka KV; Reif A; Sommer C
J Neural Transm (Vienna); 2012 Aug; 119(8):981-5. PubMed ID: 22331304
[TBL] [Abstract][Full Text] [Related]
15. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease.
Murinson BB; Guarnaccia JB
Neurology; 2008 Dec; 71(24):1955-8. PubMed ID: 18971449
[TBL] [Abstract][Full Text] [Related]
16. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies.
Dalakas MC; Li M; Fujii M; Jacobowitz DM
Neurology; 2001 Sep; 57(5):780-4. PubMed ID: 11552003
[TBL] [Abstract][Full Text] [Related]
17. Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome.
Dalakas MC
Exp Neurol; 2013 Sep; 247():303-7. PubMed ID: 23485793
[No Abstract] [Full Text] [Related]
18. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome.
Jarius S; Stich O; Speck J; Rasiah Ch; Wildemann B; Meinck HM; Rauer S
J Neuroimmunol; 2010 Dec; 229(1-2):219-24. PubMed ID: 20813415
[TBL] [Abstract][Full Text] [Related]
19. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome.
Burbelo PD; Groot S; Dalakas MC; Iadarola MJ
Biochem Biophys Res Commun; 2008 Feb; 366(1):1-7. PubMed ID: 18047830
[TBL] [Abstract][Full Text] [Related]
20. Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.
Manto MU; Hampe CS; Rogemond V; Honnorat J
Orphanet J Rare Dis; 2011 Feb; 6():3. PubMed ID: 21294897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
